Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 3/20 | 0.47 |
| ▸ | MAPT | P10636 | 8/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALPG | P10696 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2552051 | 0.86 | LMNA (0.52) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL20797675 | 0.84 | KAT2B (0.44) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL20797669 | 0.83 | KAT2B (0.41) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL20797419 | 0.83 | KAT2B (0.49) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL982086 | 0.81 | KAT2B (0.48) | KAT2BMAPTRAB9ANPC1KMT2A | |
| SCHEMBL17819079 | 0.81 | KAT2B (0.56) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL1421193 | 0.80 | KAT2B (0.52) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL13728019 | 0.80 | MAPT (0.48) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL20810699 | 0.80 | KDM4E (0.46) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL20797804 | 0.79 | PTGER4 (0.39) | KAT2BMAPTRAB9ASMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019049061-A1 | 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-03-14 | — | — | WO | disclosed |
| WO-2019049061-A1 | 5-(1 H-BENZO[D]IMIDAZO-2-YL)-PYRIDIN-2-AMINE AND 5-(3H-IMIDAZO[4,5-B]PYRIDIN-6-YL)-PYRIDIN-2-AMINE DERIVATIVES AS C-MYC AND P300/CBP HISTONE ACETYLTRANSFERASE INHIBITORS FOR TREATING CANCER | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-03-14 | — | — | WO | disclosed |